Skip to content
Study details
Enrolling now

Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction

Medical College of Wisconsin
NCT IDNCT05223322ClinicalTrials.gov data as of Apr 2026
Target enrollment

80

Study length

about 4.3 years

Ages

18–100

Sex

Female only

Locations

2 sites in IL, WI

About this study

This trial is testing a treatment called Taking Charge during Treatment (TCT) to see if it helps with inflammation and problems with blood vessels caused by cancer treatment. The goal is to learn more about how cancer treatments affect blood vessel health, specifically in women.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Taking Charge during Treatment (TCT) Intervention

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low10%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Secondary: Cardiac function - Pulse Wave Velocity, Cognitive Function, Cytokine analysis, Endothelial function, Flow Mediated Dilation, Hospital Anxiety and Depression Scale, PROMIS - Pain Interference, PROMIS - Social Support

Body systems

Oncology